 | • レポートコード：20QY06-03625 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ペット用ワクチンのグローバル市場について種類別（弱毒生ワクチン、複合ワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン）、用途別（犬、鳥、猫）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ペット用ワクチン市場の概要 ・世界の主要地域別ペット用ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のペット用ワクチン市場規模2015-2026：種類別（弱毒生ワクチン、複合ワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン） ・世界のペット用ワクチン市場規模2015-2026：用途別（犬、鳥、猫） ・ペット用ワクチンの北米市場規模2015-2020 ・ペット用ワクチンのヨーロッパ市場規模2015-2020 ・ペット用ワクチンの中国市場規模2015-2020 ・ペット用ワクチンの日本市場規模2015-2020 ・ペット用ワクチンの東南アジア市場規模2015-2020 ・ペット用ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bayer Healthcare、Vetoquinol S.A、Boehringer Ingelheim、Ceva、Eli Lilly、Heska Co.、Merck Animal Health、Merial (Sanofi)、Virbac、Zoetis (Pfizer)） ・ペット用ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ペット用ワクチンの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Pet Vaccine Market
The global Pet Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Pet Vaccine Scope and Market Size
The global Pet Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pet Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pet Vaccine market is segmented into
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Segment by Application, the Pet Vaccine market is segmented into
Canine
Avian
Feline
The Pet Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Pet Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pet Vaccine Market Share Analysis
Pet Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Vaccine business, the date to enter into the Pet Vaccine market, Pet Vaccine product introduction, recent developments, etc.
The major vendors covered:
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Table of Contents
1 Pet Vaccine Market Overview
1.1 Pet Vaccine Product Scope
1.2 Pet Vaccine Segment by Type
1.2.1 Global Pet Vaccine Sales by Type (2020-2026)
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Pet Vaccine Segment by Application
1.3.1 Global Pet Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Canine
1.3.3 Avian
1.3.4 Feline
1.4 Pet Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pet Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Pet Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Pet Vaccine Price Trends (2015-2026)
2 Pet Vaccine Estimate and Forecast by Region
2.1 Global Pet Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pet Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pet Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Pet Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Pet Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pet Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pet Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pet Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Pet Vaccine Estimates and Projections (2015-2026)
2.4.3 China Pet Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Pet Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pet Vaccine Estimates and Projections (2015-2026)
2.4.6 India Pet Vaccine Estimates and Projections (2015-2026)
3 Global Pet Vaccine Competition Landscape by Players
3.1 Global Top Pet Vaccine Players by Sales (2015-2020)
3.2 Global Top Pet Vaccine Players by Revenue (2015-2020)
3.3 Global Pet Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Vaccine as of 2019)
3.4 Global Pet Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Pet Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pet Vaccine Players (Opinion Leaders)
4 Global Pet Vaccine Market Size by Type
4.1 Global Pet Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Pet Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Pet Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Pet Vaccine Price by Type (2014-2020)
4.2 Global Pet Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pet Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pet Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Pet Vaccine Price Forecast by Type (2021-2026)
5 Global Pet Vaccine Market Size by Application
5.1 Global Pet Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Pet Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Pet Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Pet Vaccine Price by Application (2015-2020)
5.2 Global Pet Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pet Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pet Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pet Vaccine Price Forecast by Application (2021-2026)
3 North America Pet Vaccine Market Facts & Figures
3.2 North America Pet Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Pet Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Pet Vaccine Sales Market Share by Application (2015-2020)
4 Europe Pet Vaccine Market Facts & Figures
4.2 Europe Pet Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Pet Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Pet Vaccine Sales Market Share by Application (2015-2020)
5 China Pet Vaccine Market Facts & Figures
5.2 China Pet Vaccine Sales Market Share by Company (2015-2020)
5.3 China Pet Vaccine Sales Market Share by Type (2015-2020)
5.4 China Pet Vaccine Sales Market Share by Application (2015-2020)
6 Japan Pet Vaccine Market Facts & Figures
6.2 Japan Pet Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Pet Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Pet Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Pet Vaccine Market Facts & Figures
7.2 Southeast Asia Pet Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pet Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pet Vaccine Sales Market Share by Application (2015-2020)
8 India Pet Vaccine Market Facts & Figures
8.2 India Pet Vaccine Sales Market Share by Company (2015-2020)
8.3 India Pet Vaccine Sales Market Share by Type (2015-2020)
8.4 India Pet Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pet Vaccine Business
12.1 Bayer Healthcare
12.1.1 Bayer Healthcare Pet Vaccine Corporation Information
12.1.2 Bayer Healthcare Pet Vaccine Business Overview and Total Revenue
12.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Healthcare Pet Vaccine Products Offered
12.1.5 Bayer Healthcare Recent Development
12.2 Vetoquinol S.A
12.2.1 Vetoquinol S.A Pet Vaccine Corporation Information
12.2.2 Vetoquinol S.A Pet Vaccine Business Overview and Total Revenue
12.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Vetoquinol S.A Pet Vaccine Products Offered
12.2.5 Vetoquinol S.A Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Pet Vaccine Corporation Information
12.3.2 Boehringer Ingelheim Pet Vaccine Business Overview and Total Revenue
12.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Pet Vaccine Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Ceva
12.4.1 Ceva Pet Vaccine Corporation Information
12.4.2 Ceva Pet Vaccine Business Overview and Total Revenue
12.4.3 Ceva Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Ceva Pet Vaccine Products Offered
12.4.5 Ceva Recent Development
12.5 Eli Lilly
12.5.1 Eli Lilly Pet Vaccine Corporation Information
12.5.2 Eli Lilly Pet Vaccine Business Overview and Total Revenue
12.5.3 Eli Lilly Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Eli Lilly Pet Vaccine Products Offered
12.5.5 Eli Lilly Recent Development
12.6 Heska Co.
12.6.1 Heska Co. Pet Vaccine Corporation Information
12.6.2 Heska Co. Pet Vaccine Business Overview and Total Revenue
12.6.3 Heska Co. Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Heska Co. Pet Vaccine Products Offered
12.6.5 Heska Co. Recent Development
12.7 Merck Animal Health
12.7.1 Merck Animal Health Pet Vaccine Corporation Information
12.7.2 Merck Animal Health Pet Vaccine Business Overview and Total Revenue
12.7.3 Merck Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck Animal Health Pet Vaccine Products Offered
12.7.5 Merck Animal Health Recent Development
12.8 Merial (Sanofi)
12.8.1 Merial (Sanofi) Pet Vaccine Corporation Information
12.8.2 Merial (Sanofi) Pet Vaccine Business Overview and Total Revenue
12.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merial (Sanofi) Pet Vaccine Products Offered
12.8.5 Merial (Sanofi) Recent Development
12.9 Virbac
12.9.1 Virbac Pet Vaccine Corporation Information
12.9.2 Virbac Pet Vaccine Business Overview and Total Revenue
12.9.3 Virbac Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Virbac Pet Vaccine Products Offered
12.9.5 Virbac Recent Development
12.10 Zoetis (Pfizer)
12.10.1 Zoetis (Pfizer) Pet Vaccine Corporation Information
12.10.2 Zoetis (Pfizer) Pet Vaccine Business Overview and Total Revenue
12.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Zoetis (Pfizer) Pet Vaccine Products Offered
12.10.5 Zoetis (Pfizer) Recent Development
13 Pet Vaccine Manufacturing Cost Analysis
13.1 Pet Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pet Vaccine
13.4 Pet Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pet Vaccine Distributors List
14.3 Pet Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pet Vaccine Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Pet Vaccine Sales (K Doses) Comparison by Application (2020-2026)
Table 3. Global Market Pet Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Pet Vaccine Sales (K Doses) by Region (2015-2020)
Table 5. Global Pet Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Pet Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Pet Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Pet Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 9. Global Pet Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Pet Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Pet Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Pet Vaccine (K Doses) of Key Companies (2015-2020)
Table 13. Global Pet Vaccine Sales Share by Company (2015-2020)
Table 14. Global Pet Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Pet Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Pet Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Vaccine as of 2019)
Table 17. Global Pet Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers Pet Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Pet Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Pet Vaccine Players
Table 22. Global Pet Vaccine Sales (K Doses) by Type (2015-2020)
Table 23. Global Pet Vaccine Sales Share by Type (2015-2020)
Table 24. Global Pet Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Pet Vaccine Price (K Doses) by Type (2015-2020)
Table 26. Global Pet Vaccine Sales Share by Type (2021-2026)
Table 27. Global Pet Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Pet Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Pet Vaccine Price (K Doses) by Type (2021-2026)
Table 30. Global Pet Vaccine Sales (K Doses) by Application (2015-2020)
Table 31. Global Pet Vaccine Sales Share by Application (2015-2020)
Table 32. Global Pet Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Pet Vaccine Price (K Doses) by Application (2015-2020)
Table 34. Global Pet Vaccine Sales (K Doses) by Application (2021-2026)
Table 35. Global Pet Vaccine Sales Share by Application (2021-2026)
Table 36. Global Pet Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Pet Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Pet Vaccine Price (K Doses) by Application (2021-2026)
Table 39. United States Pet Vaccine Sales (K Doses) by Company (2015-2020)
Table 40. United States Pet Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Pet Vaccine Sales (K Doses) by Type (2015-2020)
Table 42. United States Pet Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Pet Vaccine Sales (K Doses) by Application (2015-2020)
Table 44. United States Pet Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Pet Vaccine Sales (K Doses) by Company (2015-2020)
Table 46. Europe Pet Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Pet Vaccine Sales (K Doses) by Type (2015-2020)
Table 48. Europe Pet Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Pet Vaccine Sales (K Doses) by Application (2015-2020)
Table 50. Europe Pet Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Pet Vaccine Sales (K Doses) by Company (2015-2020)
Table 52. China Pet Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Pet Vaccine Sales (K Doses) by Type (2015-2020)
Table 54. China Pet Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Pet Vaccine Sales (K Doses) by Application (2015-2020)
Table 56. China Pet Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Pet Vaccine Sales (K Doses) by Company (2015-2020)
Table 58. Japan Pet Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Pet Vaccine Sales (K Doses) by Type (2015-2020)
Table 60. Japan Pet Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Pet Vaccine Sales (K Doses) by Application (2015-2020)
Table 62. Japan Pet Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Pet Vaccine Sales (K Doses) by Company (2015-2020)
Table 64. Southeast Asia Pet Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Pet Vaccine Sales (K Doses) by Type (2015-2020)
Table 66. Southeast Asia Pet Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Pet Vaccine Sales (K Doses) by Type (2015-2020)
Table 68. Southeast Asia Pet Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Pet Vaccine Sales (K Doses) by Company (2015-2020)
Table 70. India Pet Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Pet Vaccine Sales (K Doses) by Type (2015-2020)
Table 72. India Pet Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Pet Vaccine Sales (K Doses) by Application (2015-2020)
Table 74. India Pet Vaccine Sales Market Share by Application (2015-2020)
Table 75. Bayer Healthcare Corporation Information
Table 76. Bayer Healthcare Description and Business Overview
Table 77. Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Bayer Healthcare Pet Vaccine Product
Table 79. Bayer Healthcare Recent Development
Table 80. Vetoquinol S.A Corporation Information
Table 81. Vetoquinol S.A Description and Business Overview
Table 82. Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Vetoquinol S.A Pet Vaccine Product
Table 84. Vetoquinol S.A Recent Development
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Boehringer Ingelheim Pet Vaccine Product
Table 89. Boehringer Ingelheim Recent Development
Table 90. Ceva Corporation Information
Table 91. Ceva Description and Business Overview
Table 92. Ceva Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Ceva Pet Vaccine Product
Table 94. Ceva Recent Development
Table 95. Eli Lilly Corporation Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Eli Lilly Pet Vaccine Product
Table 99. Eli Lilly Recent Development
Table 100. Heska Co. Corporation Information
Table 101. Heska Co. Description and Business Overview
Table 102. Heska Co. Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Heska Co. Pet Vaccine Product
Table 104. Heska Co. Recent Development
Table 105. Merck Animal Health Corporation Information
Table 106. Merck Animal Health Description and Business Overview
Table 107. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Merck Animal Health Pet Vaccine Product
Table 109. Merck Animal Health Recent Development
Table 110. Merial (Sanofi) Corporation Information
Table 111. Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Merial (Sanofi) Description and Business Overview
Table 113. Merial (Sanofi) Pet Vaccine Product
Table 114. Merial (Sanofi) Recent Development
Table 115. Virbac Corporation Information
Table 116. Virbac Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Virbac Description and Business Overview
Table 118. Virbac Pet Vaccine Product
Table 119. Virbac Recent Development
Table 120. Zoetis (Pfizer) Corporation Information
Table 121. Zoetis (Pfizer) Description and Business Overview
Table 122. Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Zoetis (Pfizer) Pet Vaccine Product
Table 124. Zoetis (Pfizer) Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Pet Vaccine Distributors List
Table 128. Pet Vaccine Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Vaccine Product Picture
Figure 2. Global Pet Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pet Vaccine Market Share by Application in 2020 & 2026
Figure 6. Canine Examples
Figure 7. Avian Examples
Figure 8. Feline Examples
Figure 9. Global Pet Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 10. Global Pet Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Pet Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 12. Global Pet Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Pet Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Pet Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Pet Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 16. Europe Pet Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Pet Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Pet Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Pet Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Pet Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Pet Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pet Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Pet Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Pet Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Pet Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Pet Vaccine Players Market Share by Revenue in Pet Vaccine 2015 & 2019
Figure 27. Pet Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Pet Vaccine Revenue Share by Type (2015-2020)
Figure 29. Global Pet Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Pet Vaccine Revenue Share by Application (2015-2020)
Figure 31. Global Pet Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Pet Vaccine Sales Market Share by Type in 2019
Figure 33. United States Pet Vaccine Sales Market Share by Type in 2019
Figure 34. Europe Pet Vaccine Sales Market Share by Company in 2019
Figure 35. Europe Pet Vaccine Sales Market Share by Type in 2019
Figure 36. Europe Pet Vaccine Sales Market Share by Application in 2019
Figure 37. China Pet Vaccine Sales Market Share by Company in 2019
Figure 38. China Pet Vaccine Sales Market Share by Type in 2019
Figure 39. China Pet Vaccine Sales Market Share by Application in 2019
Figure 40. Japan Pet Vaccine Sales Market Share by Company in 2019
Figure 41. Japan Pet Vaccine Sales Market Share by Type in 2019
Figure 42. Japan Pet Vaccine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Pet Vaccine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Pet Vaccine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Pet Vaccine Sales Market Share by Application in 2019
Figure 46. India Pet Vaccine Sales Market Share by Company in 2019
Figure 47. India Pet Vaccine Sales Market Share by Type in 2019
Figure 48. India Pet Vaccine Sales Market Share by Application in 2019
Figure 49. Bayer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Vetoquinol S.A Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Ceva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Heska Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Merial (Sanofi) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Virbac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Zoetis (Pfizer) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Pet Vaccine
Figure 61. Manufacturing Process Analysis of Pet Vaccine
Figure 62. Pet Vaccine Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
インフルエンザワクチンの世界市場レポート2020 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…- H7N9ワクチンの世界市場レポート2020 Market Analysis and Insights: Global H7N9 Vaccines Market The global H7N9 Vaccines market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global H7N9 Vaccines Scope and Market Size The global H7N9 Vaccines market is se…
- HPV治療ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global HPV Therapeutic Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HPV Therapeutic Vacc…
- 非感染性髄膜炎用ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Vaccine for Non-infectious Meningitis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1 million by 2025, from USD 1 million in 2019. The Vaccine…
- マラリアワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Malaria Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.4% in the forecast period of 2020 to 2025 and will expected to reach USD 23 million by 2025, from USD 14 million in 2019. The Malaria Vaccines market re…